Both drugs reduced office heart rate after 12 weeks of treatment. This should be regarded as a desirable goal of hypertensive therapy [22] because no obvious sympathetic reflex activation seems to ...
Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...
The US Court of Appeals for the Federal Circuit has reversed the New Jersey District Court's dismissal of Pfizer's patent infringement action against Dr Reddy's Laboratories' generic version of ...
However, many of the leading drugs face patent expiration in the next 5 years, including Pfizer's Norvasc (amlodipine), which expires in late 2007. In 2006, Norvasc generated sales of $4.9 billion.
In September 2008, the company received the US Food and Drug Administration approval for anti-hypertension drug amlodipine besylate tablets in multiple strengths and in November 2008, their ...